Author

Zubin N. Bhakta

University of Utah

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2

Frequent Co-Authors

David C. YoungiD· 2 shared Venkata YellepeddiiD· 2 shared Bryn LindleyiD· 1 shared Emi Radetich· 1 shared Laurie Leclair· 1 shared Madison ParrotiD· 1 shared Manav JainiD· 1 shared Rachel HudsoniD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

David C. YoungORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintJun 26, 2025

Population Pharmacokinetics and Probability of Target Attainment Analysis of Vancomycin Following Intermittent and Continuous Infusion in Adults with Cystic Fibrosis

Manav Jain, Rachel Hudson, Zubin N. Bhakta…·Venkata Yellepeddi

This study uses population pharmacokinetics to evaluate vancomycin dosing strategies in adults with cystic fibrosis, finding optimal regimens for efficacy and safety.

1 citation

humanclinical cohort / trial

𝕏 PostBluesky

Pharmacology & ToxicologyAntimicrobial Agents and ChemotherapyPeer-reviewedDec 7, 2023

Population Pharmacokinetics and Target Attainment Analysis of Vancomycin after Intermittent Dosing in Adults with Cystic Fibrosis

Venkata Yellepeddi, Bryn Lindley, Emi Radetich…·David C. Young

This study develops a population pharmacokinetic model for vancomycin in adults with cystic fibrosis and evaluates dosing scenarios to achieve target drug exposure.

8 citations

humanclinical cohort / trial

𝕏 PostBluesky